Edwin Moses is a serial entrepreneur and value creator in European life science companies, currently serving as the Chairman of the Board at LabGenius Ltd, Dark Blue Therapeutics Ltd, NanoSyrinx Ltd, and Avantium NV. With 25 years of board-level experience, Edwin has successfully led IPOs for Oxford Asymmetry International plc and Ablynx nv, raising over €500M in equity and debt financing. Previously, Edwin held roles such as CEO, Chairman, and European Marketing Manager across various companies, demonstrating expertise in high-value service provision to the pharmaceutical industry and drug discovery. Edwin earned a first-class honours degree and a Ph.D. in chemistry from Sheffield University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices